RetractedArticleHeliyon2024

PTK6: An emerging biomarker for prognosis and immunotherapeutic response in clear cell renal carcinoma (KIRC).

Lizhen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.